A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod

Clinical trial NCT04819464 · COMPLETED

Trial details

NCT number: NCT04819464
Sponsor: Viatris Innovation GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Impairment

Start date: 2021-08-25
Primary completion: 2024-08-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.